Ausgabe 1/2015
Inhalt (41 Artikel)
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Norikazu Yamada, Atsushi Hirayama, Hideaki Maeda, Satoru Sakagami, Hiroo Shikata, Martin H Prins, Anthonie WA Lensing, Masaharu Kato, Junichi Onuma, Yuki Miyamoto, Kazuma Iekushi, Mariko Kajikawa
Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects
Paul P Dobesh, Jamela F Urban, Scott W Shurmur, Julie H Oestreich
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
Elena N Lipets, Fazoil I Ataullakhanov
Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects
Mikhail A Panteleev, Hendrik Coenraad Hemker
A randomized, open-label trial of edoxaban in Japanese patients with severe renal impairment undergoing lower-limb orthopedic surgery
Takeshi Fuji, Satoru Fujita, Yohko Kawai, Yasuyuki Abe, Tetsuya Kimura, Masayuki Fukuzawa, Kenji Abe, Shintaro Tachibana
Superior vena cava syndrome revealing a Behçet’s disease
Simon Antoine Sarr, Pape Diadie Fall, Mouhamadou Chérif Mboup, Khadidiatou Dia, Malick Bodian, Modou Jobe
Assays of different aspects of haemostasis – what do they measure?
Nahreen Tynngård, Tomas L Lindahl, Sofia Ramström
A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients with active cancer hospitalized with an acute medical illness
Patricia Moretto, Junghyun Park, Marc Rodger, Grégoire Le Gal, Marc Carrier
“Role of the adipocyte hormone leptin in cardiovascular diseases – a study from Chennai based Population”
Devarajan Nalini, Rajendran Karthick, Vijay Shirin, Ganesan Manohar, Raghunathan Malathi
Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
Norimichi Koitabashi, Nogiku Niwamae, Tetsuya Taguchi, Yoshiaki Ohyama, Noriaki Takama, Masahiko Kurabayashi
Thrombosis in inflammatory bowel diseases: what’s the link?
Martina Giannotta, Gherardo Tapete, Giacomo Emmi, Elena Silvestri, Monica Milla
Thrombosis in vasculitis: from pathogenesis to treatment
Giacomo Emmi, Elena Silvestri, Danilo Squatrito, Amedeo Amedei, Elena Niccolai, Mario Milco D’Elios, Chiara Della Bella, Alessia Grassi, Matteo Becatti, Claudia Fiorillo, Lorenzo Emmi, Augusto Vaglio, Domenico Prisco
Systemic lupus erythematosus and thrombosis
Mario Bazzan, Antonella Vaccarino, Fabio Marletto
Analysis of the accuracy of the Wells scale in assessing the probability of lower limb deep vein thrombosis in primary care patients practice
Małgorzata Dybowska, Witold Z Tomkowski, Paweł Kuca, Rafał Ubysz, Adam Jóźwik, Dariusz Chmielewski
Autoinflammatory diseases: a possible cause of thrombosis?
Micaela La Regina, Francesco Orlandini, Raffaele Manna
Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist
Luke Bamber, Dominic Muston, Euan McLeod, Anne Guillermin, Julia Lowin, Raj Patel
Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients
Priya Sriskandarajah, Katharine Webb, David Chisholm, Ravi Raobaikady, Kim Davis, Natalie Pepper, Mark E Ethell, Mike N Potter, Bronwen E Shaw
Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients
Hein Heidbuchel, Dana Berti, Manuel Campos, Lien Desteghe, Ana Parente Freixo, António Robalo Nunes, Vanessa Roldán, Vincenzo Toschi, Riitta Lassila
The role of soluble fibrin during anticoagulant therapy: a case report
Tohru Kawakami, Nobukiyo Tanaka, Hiroki Ishihara, Hiroyoshi Ohno
Inhibition of thrombin generation in human plasma by phospholipid transfer protein
Hiroshi Deguchi, Gertrud Wolfbauer, Marian C. Cheung, Yajnavalka Banerjee, Darlene J. Elias, José A. Fernández, John J. Albers, John H. Griffin
Stent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature
Takao Konishi, Tadashi Yamamoto, Naohiro Funayama, Beni Yamaguchi, Seiichiro Sakurai, Hiroshi Nishihara, Koko Yamazaki, Yusuke Kashiwagi, Yasuki Sasa, Mitsuru Gima, Hideichi Tanaka, Daisuke Hotta, Kenjiro Kikuchi
Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs
Raul Altman, Claudio Daniel Gonzalez
Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
Takeshi Fuji, Satoru Fujita, Yohko Kawai, Mashio Nakamura, Tetsuya Kimura, Masayuki Fukuzawa, Kenji Abe, Shintaro Tachibana
The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
Hernan Polo Friz, Mauro Molteni, Claudio Cimminiello
A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: balancing the risks and benefits
Alpesh Amin, Steven Deitelzweig
Unsuccessful percutaneous mechanical thrombectomy in fibrin-rich high-risk pulmonary thromboembolism
Jernej Vidmar, Igor Serša, Eduard Kralj, Peter Popovič
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
C. H. Hansen, V. Ritschel, S. Halvorsen, G. Ø. Andersen, R. Bjørnerheim, J. Eritsland, H. Arnesen, I. Seljeflot
Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study
Murray M. Bern, Diane Hazel, Elizabeth Deeran, John R. Richmond, Daniel M. Ward, Damon J. Spitz, David A. Mattingly, James V. Bono, Ronna H. Berezin, Laura Hou, Gerald B. Miley, Benjamin E. Bierbaum
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
Otto Moodley, Hadi Goubran
Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study
Bengt Zöller, Henrik Ohlsson, Jan Sundquist, Kristina Sundquist
Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population
Soudabeh Hosseini, Ebrahim Kalantar, Maryam Sadat Hosseini, Shadi Tabibian, Morteza Shamsizadeh, Akbar Dorgalaleh
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials
Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel, Martin Feuring, Jörg Kreuzer, Michael Huo, Richard J. Friedman
Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery
Christian Wurnig, Andreas Clemens, Helmuth Rauscher, Eva Kleine, Martin Feuring, Reinhard Windhager, Josef Grohs
Aspirin for primary prevention of cardiovascular disease
Jobert Richie N. Nansseu, Jean Jacques N. Noubiap
Global Thrombosis Test – a possible monitoring system for the effects and safety of dabigatran
Kazunori Otsui, Diana A. Gorog, Junichiro Yamamoto, Takayuki Yoshioka, Sachiyo Iwata, Atsushi Suzuki, Toru Ozawa, Asumi Takei, Nobutaka Inoue
Original approach for thrombolytic therapy in patients with Ilio-femoral deep vein thrombosis : 2 years follow-up
Leslie Fiengo, Federico Bucci, Elias Khalil, Bruno Salvati
The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry
Giancarlo Agnelli, Anselm K. Gitt, Rupert Bauersachs, Eva-Maria Fronk, Petra Laeis, Patrick Mismetti, Manuel Monreal, Stefan N. Willich, Wolf-Peter Wolf, Alexander T. Cohen
A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis
Marcus D Lancé